G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.

Gustavsson, A

G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. [electronic resource] - Acta oncologica (Stockholm, Sweden) 1997 - 483-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0284-186X

10.3109/02841869709001303 doi


Adult
Antibiotics, Antineoplastic--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Alkylating--administration & dosage
Antineoplastic Agents, Hormonal--administration & dosage
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bleomycin--administration & dosage
Case-Control Studies
Dacarbazine--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Female
Filgrastim
Follow-Up Studies
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematinics--administration & dosage
Hodgkin Disease--drug therapy
Humans
Male
Mechlorethamine--administration & dosage
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Nervous System--drug effects
Neutropenia--chemically induced
Prednisone--administration & dosage
Procarbazine--administration & dosage
Recombinant Proteins
Remission Induction
Retrospective Studies
Survival Rate
Thrombocytopenia--chemically induced
Treatment Outcome
Vinblastine--administration & dosage
Vincristine--administration & dosage